We are live on
!
Find out more
Lilly Endowment Portfolio holdings
AUM
$108B
1-Year Est. Return
53.87%
This Fund
S&P 500
This Quarter
Est. Return
+36.56%
1 Year Est. Return
+53.87%
3 Year Est. Return
+155.75%
5 Year Est. Return
+422.58%
10 Year Est. Return
+1,423.09%
AUM
$47.4B
AUM Growth
+$12.2B
(+35%)
Cap. Flow
-$635M
Cap. Flow
% of AUM
-1.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.08T
| $47.4B | 100% |
101,028,810
-1,515,000
| -1% | -$635M |
|
Similar funds
Lilly Endowment's Q2 2023 Portfolio in Review
As of Q2 2023, Lilly Endowment held 1 position worth $47.4B, up 35% from $35.2B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 0%. Lilly Endowment opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Lilly Endowment's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $635M.
- Lilly Endowment's ten largest holdings make up 100% of its $47.4B portfolio in Q2 2023.
- Lilly Endowment opened 0 new positions and closed 0 in Q2 2023.
- Lilly Endowment's portfolio value rose 35% quarter-over-quarter to $47.4B.
Based on Lilly Endowment's 13F filing for Q2 2023, filed 10 Jul 2023.